Delivery Order SPE2DB24D2205-SPE2DB24FDSHC
- Not listed
- This federal contract award, valued at $7,179.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical supply item, with a period of performance through December 7, 2023. The contract type is Delivery Order with a Firm Fixed Price pricing structure. There is no set-aside designation noted for this award....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The potential value of this delivery order is $3,485.16, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is part of a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML syringes. The $8,961.84 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) that the company holds with DLA Troop Support Medical to supply pharmaceuticals and medical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a potential value of $3,231.78. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside. The contract is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,961.84 firm fixed price delivery order is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product used for various healthcare needs. The contract has a ceiling value of $8,674.70 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products. The contract has a total potential value of $8,961.84 and a completion date of February 15, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, to the Department of Defense (DoD) and other government agencies. The contract, valued at $1,685.84, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical supplies. The single-award, Firm Fixed Price Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,576.64, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical supplies. The award is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDSHCDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for EUFLEXXA 20 MG/2 ML SYRINGE 2ML, with a ceiling value of $1,929.48 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 4/8/24 |